聴覚補助デバイスの世界市場 (～2032年)：製品タイプ・難聴タイプ・患者タイプ・技術別

聴覚補助デバイスの市場規模は、2023年に120億3,401万米ドルに達すると予想されていました。2025年から2032年の予測期間中はCAGR 約8.52%で成長すると見込まれています。

世界の聴覚補助デバイス市場は、いくつかの基本的要因によって急速に拡大しています。この動向の主な理由の一つは、特に高齢者層において聴力喪失の発生率が上昇していることです。各国政府や保健機関は聴覚の健康問題への認識を高めており、それが需要の増加を促しています。さらに、デジタル聴覚補助デバイスの開発やワイヤレス接続機能といった技術革新により、製品のラインナップが拡大し、より幅広い顧客層を引きつけています。消費者の可処分所得が増加していることも、生活の質を向上させる聴覚補助デバイスをより多くの人が手に入れやすくする要因となっています。

地域別インサイト

新製品の発売、聴覚デバイスの販売の拡大、審美性を高めた目立ちにくいデバイスへの高い受容など、さまざまな要因により、北米地域が予測期間中にもっとも高い成長率を示すと見込まれています。 また、政府による強力な支援や、先進的な聴覚補助デバイス開発に向けた研究の増加により、欧州は市場シェアで2番目に大きな割合を占めると予想されています。アジア太平洋地域では、高齢化の進行と聴覚インプラントの利用拡大を背景に、予測期間中にもっとも高いCAGRを記録すると予想されています。

当レポートでは、世界の聴覚補助デバイスの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

• 促進要因
  • 難聴の発生率の増加
  • 高齢者人口の増加
• 抑制要因
  • 高いコストと手頃な価格受容性の問題
  • 難聴に対する偏見と社会的受容
• 機会
  • 可処分所得と住宅購入能力の上昇
  • 技術の進歩

第5章 市場要因分析

• ポーターのファイブフォースモデル
• COVID-19による聴覚補助デバイス市場への影響
• OTC聴覚補助デバイス市場の動向
• 決済方法の分析：地域別

第6章 世界の聴覚補助デバイス市場：製品別

• 聴覚補助デバイス
• 聴覚インプラント

第7章 世界の聴覚補助デバイス市場：難聴タイプ別

• 感音難聴
• 伝音性難聴

第8章 世界の聴覚補助デバイス市場：患者タイプ別

• 成人
• 小児

第9章 世界の聴覚補助デバイス市場：技術別

• デジタル
• アナログ

第10章 世界の聴覚補助デバイス市場：エンドユーザー別

• 自己負担
• サードパーティ保険者
• Medicare/Medicaid

第11章 世界の聴覚補助デバイス市場：地域別

• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第12章 競合情勢

• 市場シェア分析

第13章 企業プロファイル

• COCHLEAR LIMITED
• GN HEARING A/S
• SONOVA
• WILLIAM DEMANT HOLDING A/S
• STARKEY
• PETROFAC
• HALLIBURTON
• ZOUNDS HEARING
• AUDINA HEARING INSTRUMENTS
• AMPLIFON

第14章 データの引用

LIST OF TABLES

• TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
• TABLE 2 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 3 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 4 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 5 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 6 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 7 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 8 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 9 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 11 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 12 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 13 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 14 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 15 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 16 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 17 US HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 18 US HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 19 US HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 20 US HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 21 US HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 22 US HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 23 US HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 24 CANADA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 25 CANADA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 26 CANADA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 27 CANADA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 28 CANADA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 29 CANADA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 30 CANADA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 31 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 32 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 33 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 34 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 35 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 36 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 37 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 38 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 39 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 40 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 41 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 42 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 43 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 44 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 45 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 46 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 47 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 48 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 49 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 50 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 51 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 52 UK HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 53 UK HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 54 UK HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 55 UK HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 56 UK HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 57 UK HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 58 UK HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 59 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 60 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 61 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 62 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 63 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 64 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 65 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 66 ITALY HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 67 ITALY HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 68 ITALY HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 69 ITALY HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 70 ITALY HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 71 ITALY HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 72 ITALY HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 73 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 74 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 75 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 76 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 77 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 78 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 79 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 80 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 81 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 82 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 83 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 84 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 85 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 86 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 87 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 88 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 89 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 90 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 91 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 92 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 93 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 94 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 95 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 96 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 97 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 98 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 99 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 100 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 101 CHINA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 102 CHINA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 103 CHINA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 104 CHINA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 105 CHINA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 106 CHINA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 107 CHINA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 108 INDIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 109 INDIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 110 INDIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 111 INDIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 112 INDIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 113 INDIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 114 INDIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 115 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 116 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 117 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 118 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 119 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 120 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 121 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 122 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 123 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 124 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 125 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 126 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 127 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 128 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 129 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 130 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 131 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 132 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 133 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 134 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 135 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 136 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 137 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 138 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 139 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 140 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 141 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 142 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 143 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 144 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 145 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 146 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 147 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 148 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 149 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 150 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 151 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 152 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 153 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 154 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 155 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 156 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 157 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 158 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 159 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 160 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 161 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 162 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 163 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 164 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 165 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 166 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 167 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 168 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 169 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 170 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 171 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 172 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 173 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 174 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 175 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 176 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 177 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 178 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 179 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018-2032 (USD MILLION)
• TABLE 180 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018-2032 (USD MILLION)
• TABLE 181 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018-2032 (USD MILLION)
• TABLE 182 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018-2032 (USD MILLION)
• TABLE 183 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 184 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018-2032 (USD MILLION)
• TABLE 185 COCHLEAR LIMITED COMPANY: PRODUCTS OFFERED
• TABLE 186 GN HEARING A/S: PRODUCTS OFFERED
• TABLE 187 SONOVA: PRODUCTS OFFERED
• TABLE 188 WILLIAM DEMANT HOLDING A/S.: PRODUCTS OFFERED
• TABLE 189 STARKEY: PRODUCTS OFFERED
• TABLE 190 PETROFAC PRODUCTS OFFERED
• TABLE 191 HALLIBURTON PRODUCTS OFFERED
• TABLE 192 ZOUNDS HEARING PRODUCTS OFFERED
• TABLE 193 AUDINA HEARING INSTRUMENTS PRODUCTS OFFERED
• TABLE 194 AUDINA HEARING INSTRUMENTS PRODUCTS OFFERED

LIST OF FIGURES

• FIGURE 1 GLOBAL HEARING AIDS MARKET, BY PRODUCT, 2023 (% SHARE)
• FIGURE 2 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2023 (% SHARE)
• FIGURE 3 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE, 2023 (% SHARE)
• FIGURE 4 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY, 2023 (% SHARE)
• FIGURE 5 GLOBAL HEARING AIDS MARKET, BY END USER, 2023 (% SHARE)
• FIGURE 6 GLOBAL HEARING AIDS MARKET MAJOR PLAYERS MARKET SHARE ANALYSIS, 2023 (%)
• FIGURE 7 COCHLEAR LIMITED COMPANY: SWOT ANALYSIS
• FIGURE 8 GN HEARING A/S: SWOT ANALYSIS
• FIGURE 9 SONOVA: SWOT ANALYSIS
• FIGURE 10 WILLIAM DEMANT HOLDING A/S.: SWOT ANALYSIS
• FIGURE 11 STARKEY: SWOT ANALYSIS
• FIGURE 12 PETROFAC SWOT ANALYSIS
• FIGURE 13 HALLIBURTON SWOT ANALYSIS
• FIGURE 14 ZOUNDS HEARING SWOT ANALYSIS
• FIGURE 15 AUDINA HEARING INSTRUMENTS SWOT ANALYSIS
• FIGURE 16 AUDINA HEARING INSTRUMENTS SWOT ANALYSIS

Global Hearing Aids Market Research Report By Product (Hearing aid devices and Hearing implants), By Type of Hear Loss (Sensorineural hearing loss and Conductive hearing loss), By Patient Type (Adults and Pediatrics), By Technology (Digital and Analog) Forecast to 2032

Market Overview

According to MRFR analysis, the size of the hearing aids market was expected to reach USD 12,034.01 million in 2023. It is projected that the hearing aids market will grow at a compound annual growth rate (CAGR) of roughly 8.52% during the forecast period (2025-2032).

The worldwide hearing aid market is expanding quickly due to several basic factors. One of the main reasons for this trend is the rising incidence of hearing loss, especially among the elderly population. Governments and health organizations worldwide are raising awareness of hearing health issues, which is driving up demand. Furthermore, technological developments such as the creation of digital hearing aids and wireless networking capabilities have expanded product offerings and drawn in a larger customer base. Growing consumer disposable income across a range of industries will make it easier for more people to afford hearing aids that can enhance their quality of life.

Market Segmentation

Hearing implants and hearing aid devices make up the two product-based categories of the global market for hearing aids.

Sensorineural and conductive hearing loss are the two categories into which the global market is separated.

Based on patient types, the market is divided into two segments: pediatrics and adults.

The global market for hearing aids is divided between digital and analog technology.

The market is divided into two divisions based on technology: digital and analog.

The end-user market is divided into three segments: private pay/out-of-pocket, third-party payer, and Medicare/Medicaid.

Regional Insights

The analysis provides market data for hearing aids in North America, Europe, Asia-Pacific, and the rest of the world. North America led the global market in 2023. Due to a variety of factors, including the launch of new products, the expanding volume of sales of hearing devices, and the strong acceptance of less conspicuous devices for higher aesthetic appeal, North America is expected to have the highest growth rate throughout the projection period. With strong government support and increased research into developing advanced hearing aids, Europe is expected to have the second-largest share. The strategic location of several companies in the region, such as GN Store Nord A/S, Senovo, Demant A/S, and WS Audiology, is also expected to support growth. The National Institute for Health and Care Excellence (NICE) estimates that 1,260 people in England currently receive cochlear implants each year. It would also encourage market growth. Asia Pacific is expected to have the highest compound annual growth rate (CAGR) over the projected period due to the aging population and the increasing usage of hearing implants. According to Hear-it.org, there are currently 3.6 billion Australians who suffer from hearing loss; by 2060, that number is expected to increase to 7.8 billion, propelling the country's economic expansion.

Key Players

Among the leading companies in the hearing aids market are Starkey Hearing Technologies, Signia, Oticon, Demant, GN Store Nord, Unitron, Eargo, Cochlear, WS Audiology, Rexton, MED-EL (Medical Electronics), William Demant Holding A/S, Amplifon, Sonova, Audina Hearing Instruments, Beltone, and Hearing Life.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 Data Mining Process
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 Secondary Research data flow:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 Primary Research DATA FLOW:
  • 3.5.2 Primary Research: Number of Interviews conducted
  • 3.5.3 Primary Research: Regional Coverage
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 Revenue Analysis Approach
• 3.7 DATA FORECASTING
  • 3.7.1 Data forecasting Type
• 3.8 DATA MODELING
  • 3.8.1 microeconomic factor analysis:
  • 3.8.2 Data modeling:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 Increasing Incidences of Hearing Loss
  • 4.2.2 Growth of Elderly/Geriatric Population
• 4.3 RESTRAINTS
  • 4.3.1 High Cost and Affordability Issues
  • 4.3.2 Stigma and Social Acceptance
• 4.4 OPPORTUNITY
  • 4.4.1 Rise in Disposable Income and Affordability
  • 4.4.2 Technological Advancements

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 Porter's Five Forces Model
    • 5.1.1.1 Threat of New Entrants
    • 5.1.1.2 Bargaining Power of Suppliers
    • 5.1.1.3 Bargaining Power of Buyers
    • 5.1.1.4 Threat of Substitutes
    • 5.1.1.5 Industry Rivalry
• 5.2 IMPACT OF COVID-19 ON HEARING AIDS MARKET
• 5.3 OTC HEARING AID MARKET TRENDS
• 5.4 PAYMENT MODE ANALYSIS BY REGION

6 GLOBAL HEARING AIDS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • 6.1.1 Hearing Aid Devices
    • 6.1.1.1 Behind-the-ear (BTE) Hearing Aids
    • 6.1.1.2 In-the-ear (ITE) Hearing Aids
    • 6.1.1.3 Canal Hearing Aids
    • 6.1.1.4 Receiver-in-the-ear (RIE) Hearing Aid
    • 6.1.1.5 Others
  • 6.1.2 Hearing Implants
    • 6.1.2.1 Cochlear Implants
    • 6.1.2.2 Bone-Anchored Hearing Aids (BAHA)

7 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS

• 7.1 INTRODUCTION
  • 7.1.1 Sensorineural Hearing Loss
  • 7.1.2 Conductive Hearing Loss

8 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE

• 8.1 INTRODUCTION
  • 8.1.1 Adults
  • 8.1.2 Pediatrics

9 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY

• 9.1 INTRODUCTION
  • 9.1.1 Digital
  • 9.1.2 Analog

10 GLOBAL HEARING AIDS MARKET, BY END USER

• 10.1 INTRODUCTION
  • 10.1.1 Private Pay/Out of Pocket
  • 10.1.2 Third Party Payer
  • 10.1.3 Medicare/Medicaid

11 GLOBAL HEARING AIDS MARKET, BY REGION

• 11.1 INTRODUCTION
  • 11.1.1 North America
    • 11.1.1.1 US
    • 11.1.1.2 Canada
    • 11.1.1.3 Mexico
  • 11.1.2 EUROPE
    • 11.1.2.1 Germany
    • 11.1.2.2 UK
    • 11.1.2.3 France
    • 11.1.2.4 Italy
    • 11.1.2.5 Spain
    • 11.1.2.6 Rest Of Europe
  • 11.1.3 ASIA-PACIFIC
    • 11.1.3.1 Japan
    • 11.1.3.2 China
    • 11.1.3.3 India
    • 11.1.3.4 Australia
    • 11.1.3.5 Rest Of Asia Pacific
  • 11.1.4 SOUTH AMERICA
    • 11.1.4.1 Brazil
    • 11.1.4.2 Colombia
    • 11.1.4.3 Rest of South America
  • 11.1.5 Middle East & Africa
    • 11.1.5.1 South Africa
    • 11.1.5.2 GCC Countries
    • 11.1.5.3 Rest of Middle East and Africa

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 MARKET SHARE ANALYSIS, 2023

13 COMPANY PROFILES

• 13.1 COCHLEAR LIMITED
  • 13.1.1 COMPANY OVERVIEW
  • 13.1.2 PRODUCTS OFFERed
  • 13.1.3 SWOT ANALYSIS
  • 13.1.4 Key Strategy
• 13.2 GN HEARING A/S
  • 13.2.1 COMPANY OVERVIEW
  • 13.2.2 PRODUCTS OFFERed
  • 13.2.3 SWOT ANALYSIS
  • 13.2.4 Key Strategy
• 13.3 SONOVA
  • 13.3.1 COMPANY OVERVIEW
  • 13.3.2 PRODUCTS OFFERed
  • 13.3.3 SWOT ANALYSIS
  • 13.3.4 Key Strategy
• 13.4 WILLIAM DEMANT HOLDING A/S
  • 13.4.1 COMPANY OVERVIEW
  • 13.4.2 PRODUCTS OFFERed
  • 13.4.3 SWOT ANALYSIS
  • 13.4.4 Key Strategy
• 13.5 STARKEY
  • 13.5.1 COMPANY OVERVIEW
  • 13.5.2 PRODUCTS OFFERed
  • 13.5.3 SWOT ANALYSIS
  • 13.5.4 Key Strategy
• 13.6 PETROFAC
  • 13.6.1 COMPANY OVERVIEW
  • 13.6.2 PRODUCTS OFFERed
  • 13.6.3 SWOT ANALYSIS
  • 13.6.4 Key Strategy
• 13.7 HALLIBURTON
  • 13.7.1 COMPANY OVERVIEW
  • 13.7.2 PRODUCTS OFFERed
  • 13.7.3 SWOT ANALYSIS
  • 13.7.4 Key Strategy
• 13.8 ZOUNDS HEARING
  • 13.8.1 COMPANY OVERVIEW
  • 13.8.2 PRODUCTS OFFERed
  • 13.8.3 SWOT ANALYSIS
  • 13.8.4 Key Strategy
• 13.9 AUDINA HEARING INSTRUMENTS
  • 13.9.1 COMPANY OVERVIEW
  • 13.9.2 PRODUCTS OFFERed
  • 13.9.3 SWOT ANALYSIS
  • 13.9.4 Key Strategy
• 13.10 AMPLIFON
  • 13.10.1 COMPANY OVERVIEW
  • 13.10.2 PRODUCTS OFFERed
  • 13.10.3 SWOT ANALYSIS
  • 13.10.4 Key Strategy

14 DATA CITATIONS